Global and Japan Aminoglycosides Antibiotics Market Insights, Forecast to 2027

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.
Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.
Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.
Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

Market Analysis and Insights: Global and Japan Aminoglycosides Antibiotics Market
This report focuses on global and Japan Aminoglycosides Antibiotics market.
In 2020, the global Aminoglycosides Antibiotics market size was US$ 1043.8 million and it is expected to reach US$ 1083.5 million by the end of 2027, with a CAGR of 0.5% during 2021-2027. In Japan the Aminoglycosides Antibiotics market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Aminoglycosides Antibiotics Scope and Market Size
Aminoglycosides Antibiotics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Aminoglycosides Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Aminoglycosides Antibiotics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Etimicin
Others

Segment by Application
Hospital
Clinic
Post Care Facility
Government & Military
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Jemicare
Teva
Novartis
Fangyuan-pharma
Aike Pharmaceutical
Cipla
Pfizer
Fresenius Kabi
Sun Pharma
Hikma
Lannett Company